STAT3 and ovarian cancer: STAT3 signaling has long been known to play a critical role in immune tolerance and inhibition of tumor immune surveillance [11,12], and multiple studies point to a central role for STAT3 signaling as a key driver of immune suppression by tumor-associated macrophages [13] and M2 polarization in ovarian cancer [14].